生命科学资讯

GSK gives back rights to Wave's genetic disease RNA editor

Thermo Fisher trims Massachusetts headcount with Franklin site closure

GSK plans to lay off up to 350 R&D workers across US, UK

Thermo Fisher to close Franklin site, affecting up to 80 workers - Boston.com

New CagriSema data show improvement over semaglutide

Novo combination obesity shot meets goal in diabetes trial

UPC Clarifies PI Costs Breakdown In mRNA Fight - Law360

Thermo Fisher trims Massachusetts headcount with Franklin site closure - Fierce Pharma

Thermo Fisher to close Franklin plant, lay off 80 workers - The Boston Globe

Video: UK Festival of Genomics & Biodata 2026 - Illumina

Sanofi drug, inherited from Genzyme, goes 1-for-2 in rare disease trials

Money raised by biopharma

Biopharma money raised: Jan. 1-30, 2026

GSK returns rights to Wave's RNA editing program for AATD

Early-stage investor Santé Ventures gins up $330M to spread across biotech, medtech and digital health

Roche's return to RNA continues with $1.7B deal for Sanegene program

Optellum tapped by NHS for AI-powered lung cancer diagnostic initiative

China's Newsoara pens $135M deal for remaining rights to vTv's inflammation drug

Daiichi stops internal development of next-wave ADC as key Datroway readout delayed again

Spring Health acquires Alma, expanding insurance reach in virtual mental health